Our portfolio company Oncimmune has announced encouraging interim results of an early detection programme for lung cancer in the UK which first started in 2012. With over 1.5 million deaths in 2012, lung cancer kills more people than any other cancer worldwide, and Oncimmune’s EarlyCDT-Lung blood test may be able to pick up very small early stage lung cancers symptoms which is important in countries where CT screening is simply not possible due to the cost and availability of machines.
Click here for the full press release.